United States Advisory Committee on Immunization Practices

United States Advisory Committee on Immunization Practices
Name	Advisory Committee on Immunization Practices
Formation	1964
Type	Federal advisory committee
Headquarters	Atlanta, Georgia
Leader title	Chair
Leader name	Rochelle Walensky
Parent organization	Centers for Disease Control and Prevention

United States Advisory Committee on Immunization Practices is a federal advisory committee that provides guidance on the use of vaccines and immunization schedules for populations in the United States. The committee advises the Centers for Disease Control and Prevention, the Department of Health and Human Services, and other agencies on vaccine-preventable disease control, vaccine safety, and programmatic implementation. Members include experts drawn from clinical medicine, epidemiology, public health, and related fields who synthesize evidence from domestic and international sources.

History

The committee traces its origins to policy groups active during the mid-20th century, emerging alongside initiatives such as the Vaccination Assistance Act and programs run by the National Institutes of Health, Public Health Service, and early divisions of the Centers for Disease Control and Prevention. During the Polio vaccine era and subsequent Measles and Smallpox campaigns, the committee’s predecessors shaped immunization strategy in coordination with agencies like the World Health Organization and the Pan American Health Organization. Major milestones include adoption of the childhood immunization schedule in the late 20th century, responses to the H1N1 pandemic of 2009, and deliberations during the COVID-19 pandemic with input from actors such as the Food and Drug Administration and Operation Warp Speed.

Membership and Organization

Membership is composed of non-federal voting experts and ex officio nonvoting representatives from agencies such as the Food and Drug Administration, Health Resources and Services Administration, and National Vaccine Program Office. Appointments are made through the Department of Health and Human Services with consideration of nominees from academic centers like Johns Hopkins University, Harvard Medical School, and Emory University School of Medicine. The committee organizes into workgroups and liaison roles involving institutions such as the American Academy of Pediatrics, Association of State and Territorial Health Officials, and the American Medical Association. Chairs and members have included clinicians and scientists affiliated with institutions such as Mayo Clinic, University of California San Francisco, and University of Pennsylvania.

Functions and Roles

The committee evaluates clinical trial data, observational studies, and postlicensure surveillance performed by entities like the Vaccine Adverse Event Reporting System, Vaccine Safety Datalink, and international partners including European Medicines Agency. It issues recommendations on vaccine indications, schedules, contraindications, and use in special populations referencing evidence from trials conducted by manufacturers and reviewed by the Food and Drug Administration. The committee also develops guidance for immunization programs administered by state health departments, clinics affiliated with Community Health Centers, and systems like Medicaid and Medicare.

Recommendations and Policy Impact

Recommendations produced by the committee inform the official immunization schedule adopted by the Centers for Disease Control and Prevention and influence coverage decisions by payers such as Centers for Medicare & Medicaid Services and private insurers represented by groups like the Blue Cross Blue Shield Association. Policies guided by the committee have affected deployment during outbreaks such as Mumps and Pertussis resurgences, informed adolescent vaccination strategies including for Human papillomavirus, and directed adult immunization for diseases such as Influenza and Pneumococcal disease. Internationally, committee guidance has intersected with programs led by the Global Alliance for Vaccines and Immunization and policy frameworks by the World Bank that finance vaccine procurement.

Meetings and Decision-Making Process

The committee convenes regularly at locations including headquarters in Atlanta, Georgia and via virtual venues, holding open sessions for public comment with administrative support from the Advisory Committee on Immunization Practices Secretariat within the Centers for Disease Control and Prevention. Decision-making integrates systematic reviews from the Community Preventive Services Task Force, cost-effectiveness analyses referencing agencies such as the Agency for Healthcare Research and Quality, and deliberations informed by ethical frameworks developed by institutions like the National Academies of Sciences, Engineering, and Medicine. Votes are recorded and synopses of deliberations are provided to stakeholders including the President of the United States’s public health advisors.

Interactions with Other Agencies and Stakeholders

The committee collaborates with regulatory bodies such as the Food and Drug Administration for licensure considerations, insurance and payment entities like the Centers for Medicare & Medicaid Services for coverage implementation, and international organizations including the World Health Organization for global strategy alignment. It engages professional societies—Infectious Diseases Society of America, American Academy of Family Physicians, American College of Obstetricians and Gynecologists—and state-level organizations like the Association of State and Territorial Health Officials to operationalize guidance. Partnerships extend to academic centers, vaccine manufacturers, public advocacy groups, and surveillance networks such as the Global Polio Eradication Initiative and the European Centre for Disease Prevention and Control to coordinate research, safety monitoring, and program delivery.

Category:Public health